Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States

The US Coast Guard Academy began adenovirus vaccination of incoming cadets in 2022. Of 294 vaccine recipients, 15%–20% had mild respiratory or systemic symptoms within 10 days postvaccination but no serious adverse events after 90 days. Our findings support the continued use of adenovirus vaccines i...

Descripción completa

Detalles Bibliográficos
Autores principales: Iskander, John, Blanchet, Scott, Springer, Caitlin, Rockwell, Patrick, Thomas, Dana, Pillai, Satish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202855/
https://www.ncbi.nlm.nih.gov/pubmed/37209695
http://dx.doi.org/10.3201/eid2906.230331
_version_ 1785045506674655232
author Iskander, John
Blanchet, Scott
Springer, Caitlin
Rockwell, Patrick
Thomas, Dana
Pillai, Satish
author_facet Iskander, John
Blanchet, Scott
Springer, Caitlin
Rockwell, Patrick
Thomas, Dana
Pillai, Satish
author_sort Iskander, John
collection PubMed
description The US Coast Guard Academy began adenovirus vaccination of incoming cadets in 2022. Of 294 vaccine recipients, 15%–20% had mild respiratory or systemic symptoms within 10 days postvaccination but no serious adverse events after 90 days. Our findings support the continued use of adenovirus vaccines in congregate military settings.
format Online
Article
Text
id pubmed-10202855
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-102028552023-06-01 Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States Iskander, John Blanchet, Scott Springer, Caitlin Rockwell, Patrick Thomas, Dana Pillai, Satish Emerg Infect Dis Research Letter The US Coast Guard Academy began adenovirus vaccination of incoming cadets in 2022. Of 294 vaccine recipients, 15%–20% had mild respiratory or systemic symptoms within 10 days postvaccination but no serious adverse events after 90 days. Our findings support the continued use of adenovirus vaccines in congregate military settings. Centers for Disease Control and Prevention 2023-06 /pmc/articles/PMC10202855/ /pubmed/37209695 http://dx.doi.org/10.3201/eid2906.230331 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Iskander, John
Blanchet, Scott
Springer, Caitlin
Rockwell, Patrick
Thomas, Dana
Pillai, Satish
Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States
title Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States
title_full Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States
title_fullStr Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States
title_full_unstemmed Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States
title_short Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States
title_sort enhanced adenovirus vaccine safety surveillance in military setting, united states
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202855/
https://www.ncbi.nlm.nih.gov/pubmed/37209695
http://dx.doi.org/10.3201/eid2906.230331
work_keys_str_mv AT iskanderjohn enhancedadenovirusvaccinesafetysurveillanceinmilitarysettingunitedstates
AT blanchetscott enhancedadenovirusvaccinesafetysurveillanceinmilitarysettingunitedstates
AT springercaitlin enhancedadenovirusvaccinesafetysurveillanceinmilitarysettingunitedstates
AT rockwellpatrick enhancedadenovirusvaccinesafetysurveillanceinmilitarysettingunitedstates
AT thomasdana enhancedadenovirusvaccinesafetysurveillanceinmilitarysettingunitedstates
AT pillaisatish enhancedadenovirusvaccinesafetysurveillanceinmilitarysettingunitedstates

Ejemplares similares